Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9618)
All Articles published online
|
Publishing Process of This Article
|
Aug 26, 2014 (publication date) through Jun 10, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Usuda D, Kanda T. Peroxisome proliferator-activated receptors for hypertension. World J Cardiol 2014; 6(8): 744-754 [PMID: 25228953 DOI: 10.4330/wjc.v6.i8.744] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v6/i8/744.htm |
| Number | Citing Articles |
| 1 |
Gaojun Cai, Xinyong Zhang, Weijin Weng, Ganwei Shi, Sheliang Xue, Bifeng Zhang, Joseph Devaney. Associations between PPARG polymorphisms and the risk of essential hypertension. PLOS ONE 2017; 12(7): e0181644 doi: 10.1371/journal.pone.0181644
|
| 2 |
Yue-Xin Guo, Bo-Ya Wang, Han Gao, Rong-Xuan Hua, Lei Gao, Cheng-Wei He, Ying Wang, Jing-Dong Xu. Peroxisome Proliferator–Activated Receptor-α: A Pivotal Regulator of the Gastrointestinal Tract. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.864039
|
| 3 |
Hai-Yu Li, Mei Yang, Ze Li, Zhe Meng. Curcumin inhibits angiotensin II-induced inflammation and proliferation of rat vascular smooth muscle cells by elevating PPAR-γ activity and reducing oxidative stress. International Journal of Molecular Medicine 2017; 39(5): 1307 doi: 10.3892/ijmm.2017.2924
|
| 4 |
Yu-Ju Lin, I-Chun Lin, Hong-Ren Yu, Jiunn-Ming Sheen, Li-Tung Huang, You-Lin Tain. Early Postweaning Treatment with Dimethyl Fumarate Prevents Prenatal Dexamethasone- and Postnatal High-Fat Diet-Induced Programmed Hypertension in Male Rat Offspring. Oxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/5343462
|
| 5 |
Wenqi Yang, Shudan Mao, Baoze Qu, Fengxiang Zhang, Zhaolong Xu. Association of peroxisome proliferator-activated receptor delta and additional gene–smoking interaction on cardiovascular disease. Clinical and Experimental Hypertension 2017; 39(2): 114 doi: 10.1080/10641963.2016.1210623
|
| 6 |
V. I. Podzolkov, A. I. Tarzimanova. Telmisartan in the treatment of hypertensive patients. Terapevticheskii arkhiv 2017; 89(6): 110 doi: 10.17116/terarkh2017896110-113
|
| 7 |
Tufan GÜNAY, Selvi COŞAR. The relationship between the prognostic nutritional index and non-dipping blood pressure pattern in patients with newly diagnosed hypertension. Anatolian Current Medical Journal 2023; 5(3): 287 doi: 10.38053/acmj.1258111
|
| 8 |
Mahashweta Basu, Mahfuza Sharmin, Avinash Das, Nishanth Ulhas Nair, Kun Wang, Joo Sang Lee, Yen-Pei Christy Chang, Eytan Ruppin, Sridhar Hannenhalli. Prediction and Subtyping of Hypertension from Pan-Tissue Transcriptomic and Genetic Analyses. Genetics 2017; 207(3): 1121 doi: 10.1534/genetics.117.300280
|
| 9 |
Laise Aline Martins dos Santos, Gabriel Barros Rodrigues, Fernanda Virgínia Barreto Mota, Maria Eduarda Rocha de França, Karla Patrícia de Souza Barbosa, Wilma Helena de Oliveira, Sura Wanessa Santos Rocha, Deniele Bezerra Lós, Amanda Karolina Soares Silva, Teresinha Gonçalves da Silva, Christina Alves Peixoto. New thiazolidinedione LPSF/GQ-2 inhibits NFκB and MAPK activation in LPS-induced acute lung inflammation. International Immunopharmacology 2018; 57: 91 doi: 10.1016/j.intimp.2018.02.011
|
| 10 |
N. A. Petunina, E. V. Goncharova, I. A. Kuzina, L. V. Nedosugova, N. S. Martirosyan, M. Е. Теlnova. The role of pioglitazone in the fight against insulin resistance, atherosclerosis, cardiovascular disease, and non-alcoholic fatty liver disease. Diabetes mellitus 2022; 25(5): 504 doi: 10.14341/DM12859
|
| 11 |
Noboru Toda, Tomio Okamura. Cigarette smoking impairs nitric oxide-mediated cerebral blood flow increase: Implications for Alzheimer's disease. Journal of Pharmacological Sciences 2016; 131(4): 223 doi: 10.1016/j.jphs.2016.07.001
|
| 12 |
Fengying Gao, Satoru Yokoyama, Makoto Fujimoto, Koichi Tsuneyama, Ikuo Saiki, Yutaka Shimada, Yoshihiro Hayakawa. Effect of Keishibukuryogan on Genetic and Dietary Obesity Models. Evidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/801291
|
| 13 |
Lorenzo Nesti, Domenico Tricò, Alessandro Mengozzi, Andrea Natali. Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug. Cardiovascular Diabetology 2021; 20(1) doi: 10.1186/s12933-021-01294-7
|
| 14 |
Abdelrahman Ibrahim Abushouk, Mostafa Wanees Ahmed El-Husseny, Eshak I. Bahbah, Ahmed Elmaraezy, Aya Ashraf Ali, Asmaa Ashraf, Mohamed M. Abdel-Daim. Peroxisome proliferator-activated receptors as therapeutic targets for heart failure. Biomedicine & Pharmacotherapy 2017; 95: 692 doi: 10.1016/j.biopha.2017.08.083
|
| 15 |
You-Lin Tain, Julie Chan, Chien-Te Lee, Chien-Ning Hsu. Maternal Melatonin Therapy Attenuates Methyl-Donor Diet-Induced Programmed Hypertension in Male Adult Rat Offspring. Nutrients 2018; 10(10): 1407 doi: 10.3390/nu10101407
|
| 16 |
Balamurugan Ramatchandirin, Alexia Pearah, Ling He. Regulation of Liver Glucose and Lipid Metabolism by Transcriptional Factors and Coactivators. Life 2023; 13(2): 515 doi: 10.3390/life13020515
|
| 17 |
Luz Ibarra-Lara, Leonardo Del Valle-Mondragón, Elizabeth Soria-Castro, Juan C. Torres-Narváez, Francisca Pérez-Severiano, María Sánchez-Aguilar, Margarita Ramírez-Ortega, Luz G. Cervantes-Pérez, Gustavo S. Pastelín-Hernández, Víctor H. Oidor-Chan, Gabriela Zarco-Olvera, Alicia Sánchez-Mendoza. Peroxisome proliferator-activated receptor-α stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle. Pharmacological Reports 2016; 68(4): 692 doi: 10.1016/j.pharep.2016.03.002
|
| 18 |
Maria Florencia Albertoni Borghese, Lucas Humberto Oronel, Maria Del Carmen Ortiz, Mónica Patricia Majowicz. Hypertension and renal disease programming: focus on the early postnatal period. Clinical Science 2022; 136(17): 1303 doi: 10.1042/CS20220293
|
| 19 |
Kai‐Chun Cheng, Wei‐Ting Chang, Yingxiao Li, Yung‐Ze Cheng, Juei‐Tang Cheng, Zhih‐Cherng Chen. GW0742 activates peroxisome proliferator‐activated receptor δ to reduce free radicals and alleviate cardiac hypertrophy induced by hyperglycemia in cultured H9c2 cells. Journal of Cellular Biochemistry 2018; 119(11): 9532 doi: 10.1002/jcb.27270
|
| 20 |
Huang-Jun Liu, Hai-Han Liao, Zheng Yang, Qi-Zhu Tang. Peroxisome Proliferator-Activated Receptor-γIs Critical to Cardiac Fibrosis. PPAR Research 2016; 2016: 1 doi: 10.1155/2016/2198645
|
| 21 |
Wang-Soo Lee, Jaetaek Kim. Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions. PPAR Research 2015; 2015: 1 doi: 10.1155/2015/271983
|
| 22 |
Yunkuo Li, Yujie Pan, Xiaodong Zhao, Shouwang Wu, Faping Li, Yuxiong Wang, Bin Liu, Yanghe Zhang, Xin Gao, Yishu Wang, Honglan Zhou. Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression. Clinical Nutrition 2024; 43(2): 332 doi: 10.1016/j.clnu.2023.12.005
|
| 23 |
Anna M. Catinis, Ashlin J. Hinojosa, Claudia Leonardi, Michael W. Cook. Hepatic Vagotomy in Patients With Obesity Leads to Improvement of the Cholesterol to High-Density Lipoprotein Ratio. Obesity Surgery 2023; 33(12): 3740 doi: 10.1007/s11695-023-06800-2
|
| 24 |
You-Lin Tain, Chien-Ning Hsu, Julie Chan. PPARs Link Early Life Nutritional Insults to Later Programmed Hypertension and Metabolic Syndrome. International Journal of Molecular Sciences 2015; 17(1): 20 doi: 10.3390/ijms17010020
|
| 25 |
Aman Upaganlawar, Chandrashekhar Upasani, Stella Amarachi Ihim. Current Thoughts on Dementia. 2022; : 387 doi: 10.1007/978-981-16-7606-2_14
|
| 26 |
Jun Guo, Jue Wu, Qinyuan He, Mengshu Zhang, Hong Li, Yanping Liu. The Potential Role of PPARs in the Fetal Origins of Adult Disease. Cells 2022; 11(21): 3474 doi: 10.3390/cells11213474
|
| 27 |
Syeda Momna Ishtiaq, Muhammad Imran Arshad, Junaid Ali Khan. PPARγ signaling in hepatocarcinogenesis: Mechanistic insights for cellular reprogramming and therapeutic implications. Pharmacology & Therapeutics 2022; 240: 108298 doi: 10.1016/j.pharmthera.2022.108298
|
| 28 |
Fangting Zhou, Xiaohong Teng, Pei Wang, Yongyun Zhang, Yongwang Miao. Isolation, identification, expression and subcellular localization of PPARG gene in buffalo mammary gland. Gene 2020; 759: 144981 doi: 10.1016/j.gene.2020.144981
|
| 29 |
Mahashweta Basu, Kun Wang, Eytan Ruppin, Sridhar Hannenhalli. Predicting tissue-specific gene expression from whole blood transcriptome. Science Advances 2021; 7(14) doi: 10.1126/sciadv.abd6991
|
| 30 |
Xiao-Hua Yu, Xi-Long Zheng, Chao-Ke Tang. . Advances in Clinical Chemistry 2015; 71: 171 doi: 10.1016/bs.acc.2015.06.005
|
| 31 |
Futoshi Nakamura, Yu Ishida, Daisuke Sawada, Nobuhisa Ashida, Tomonori Sugawara, Manami Sakai, Tsuyoshi Goto, Teruo Kawada, Shigeru Fujiwara. Fragmented Lactic Acid Bacterial Cells Activate Peroxisome Proliferator-Activated Receptors and Ameliorate Dyslipidemia in Obese Mice. Journal of Agricultural and Food Chemistry 2016; 64(12): 2549 doi: 10.1021/acs.jafc.5b05827
|
| 32 |
John D. Imig. Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension. Frontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1186477
|
| 33 |
Nan Lin, Yanyan Zhang, Shu Su, Yanqiu Feng, Bin Wang, Zhiwen Li. Exposure characteristics of legacy and novel per- and polyfluoroalkyl substances in blood and association with hypertension among low-exposure population. Journal of Hazardous Materials 2023; 459: 132185 doi: 10.1016/j.jhazmat.2023.132185
|
| 34 |
Salvador Sierra, Natasha Luquin, Judith Navarro-Otano. The endocannabinoid system in cardiovascular function: novel insights and clinical implications. Clinical Autonomic Research 2018; 28(1): 35 doi: 10.1007/s10286-017-0488-5
|
| 35 |
Lu Han, Wen-Jun Shen, Stefanie Bittner, Fredric B Kraemer, Salman Azhar. PPARs: Regulators of Metabolism and As Therapeutic Targets in Cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ. Future Cardiology 2017; 13(3): 279 doi: 10.2217/fca-2017-0019
|
| 36 |
Lai Xue, Kun Wu, Hongmei Qiu, Bo Huang, Rongchun Chen, Wei Xie, Qingsong Jiang. Polydatin exhibits the hepatoprotective effects through PPAR-α/-β signaling pathway in Streptozocin-induced diabetic mice. Journal of Functional Foods 2017; 36: 341 doi: 10.1016/j.jff.2017.07.015
|
| 37 |
Stefan Reinhold, W. Matthijs Blankesteijn, Sébastien Foulquier. The Interplay of WNT and PPARγ Signaling in Vascular Calcification. Cells 2020; 9(12): 2658 doi: 10.3390/cells9122658
|
| 38 |
Xin Sun, Yan Zhang, Meilin Xie. The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease. Acta Pharmaceutica 2017; 67(1): 1 doi: 10.1515/acph-2017-0007
|
| 39 |
Hugo Christian Monroy-Ramirez, Marina Galicia-Moreno, Ana Sandoval-Rodriguez, Alejandra Meza-Rios, Arturo Santos, Juan Armendariz-Borunda. PPARs as Metabolic Sensors and Therapeutic Targets in Liver Diseases. International Journal of Molecular Sciences 2021; 22(15): 8298 doi: 10.3390/ijms22158298
|
| 40 |
Yi Sak Kim, Hye-Mi Lee, Jin Kyung Kim, Chul-Su Yang, Tae Sung Kim, Mingyu Jung, Hyo Sun Jin, Sup Kim, Jichan Jang, Goo Taeg Oh, Jin-Man Kim, Eun-Kyeong Jo. PPAR-α Activation Mediates Innate Host Defense through Induction of TFEB and Lipid Catabolism. The Journal of Immunology 2017; 198(8): 3283 doi: 10.4049/jimmunol.1601920
|
| 41 |
You-Lin Tain, Wei-Chia Lee, Kay Wu, Steve Leu, Julie Chan. Maternal High Fructose Intake Increases the Vulnerability to Post-Weaning High-Fat Diet-Induced Programmed Hypertension in Male Offspring. Nutrients 2018; 10(1): 56 doi: 10.3390/nu10010056
|
| 42 |
Jie Zhang, Hongmei Qiu, Jiajun Huang, Shumei Ding, Bo Huang, Qin Wu, Qingsong Jiang. Naringenin exhibits the protective effect on cardiac hypertrophy via EETs-PPARs activation in streptozocin-induced diabetic mice. Biochemical and Biophysical Research Communications 2018; 502(1): 55 doi: 10.1016/j.bbrc.2018.05.119
|
| 43 |
Fengying Gao, Satoru Yokoyama, Makoto Fujimoto, Koichi Tsuneyama, Ikuo Saiki, Yutaka Shimada, Yoshihiro Hayakawa. Comparison of two Kampo medicines in a diet‐induced mouse obesity model. Traditional & Kampo Medicine 2015; 2(2): 60 doi: 10.1002/tkm2.1021
|
| 44 |
Munawar Hussain Soomro, Cara Nichole Maesano, Barbara Heude, Carl-Gustaf Bornehag, Isabella Annesi-Maesano. The association between maternal urinary phthalate metabolites concentrations and pregnancy induced hypertension: Results from the EDEN Mother-Child Cohort. Journal of Gynecology Obstetrics and Human Reproduction 2021; 50(10): 102216 doi: 10.1016/j.jogoh.2021.102216
|
| 45 |
E.G. Sergeeva, E.G. Sergeeva, O.A. Berkovich, Z.I. Ionova, M.I. Zaraisky, E.I Baranova, E.I Baranova, Akshay Kakumanu. L162v Polymorphism of Par-Α Gene, A603g Polymorphism of Tissue Factor Gene and Risk of Coronary Heart Disease in Russian Population. Journal Of Bioinformatics And Diabetes 2019; 1(4): 1 doi: 10.14302/issn.2374-9431.jbd-19-2788
|
| 46 |
Alexandre Vallée, Bernard L. Lévy, Jacques Blacher. Interplay between the renin-angiotensin system, the canonical WNT/β-catenin pathway and PPARγ in hypertension. Current Hypertension Reports 2018; 20(7) doi: 10.1007/s11906-018-0860-4
|
| 47 |
Minjoo Kim, Minkyung Kim, Hye Jin Yoo, Jayoung Shon, Jong Ho Lee. Associations between hypertension and the peroxisome proliferator-activated receptor-δ (PPARD) gene rs7770619 C>T polymorphism in a Korean population. Human Genomics 2018; 12(1) doi: 10.1186/s40246-018-0162-6
|
| 48 |
Yang Yu, Bao-Jian Xue, Shun-Guang Wei, Zhi-Hua Zhang, Terry G. Beltz, Fang Guo, Alan Kim Johnson, Robert B. Felder. Activation of Central PPAR-γ Attenuates Angiotensin II–Induced Hypertension. Hypertension 2015; 66(2): 403 doi: 10.1161/HYPERTENSIONAHA.115.05726
|
| 49 |
Nnamdi Uche, Ivor J. Benjamin. Cardiovascular Disease in Racial and Ethnic Minority Populations. Contemporary Cardiology 2021; : 47 doi: 10.1007/978-3-030-81034-4_6
|
| 50 |
Yubo Li, Guoqiang Sun. Case-control study on association of peroxisome proliferator-activated receptor-δ and SNP-SNP interactions with essential hypertension in Chinese Han population. Functional & Integrative Genomics 2016; 16(1): 95 doi: 10.1007/s10142-015-0469-5
|
| 51 |
Saroj Chakraborty, Juthika Mandal, Xi Cheng, Sarah Galla, Anay Hindupur, Piu Saha, Beng San Yeoh, Blair Mell, Ji-Youn Yeo, Matam Vijay-Kumar, Tao Yang, Bina Joe. Diurnal Timing Dependent Alterations in Gut Microbial Composition Are Synchronously Linked to Salt-Sensitive Hypertension and Renal Damage. Hypertension 2020; 76(1): 59 doi: 10.1161/HYPERTENSIONAHA.120.14830
|
| 52 |
You-Lin Tain, Yu-Ju Lin, Jiunn-Ming Sheen, I-Chun Lin, Hong-Ren Yu, Li-Tung Huang, Chien-Ning Hsu. Resveratrol prevents the combined maternal plus postweaning high-fat-diets-induced hypertension in male offspring. The Journal of Nutritional Biochemistry 2017; 48: 120 doi: 10.1016/j.jnutbio.2017.06.007
|
| 53 |
Martin Michaelis, Florian Rothweiler, Mario Wurglics, Natália Aniceto, Michaela Dittrich, Heiko Zettl, Michael Wiese, Mark Wass, Taravat Ghafourian, Manfred Schubert-Zsilavecz, Jindrich Cinatl. Substrate-specific effects of pirinixic acid derivatives on ABCB1-mediated drug transport. Oncotarget 2016; 7(10): 11664 doi: 10.18632/oncotarget.7345
|
| 54 |
Marta Toral, Miguel Romero, Francisco Pérez-Vizcaíno, Juan Duarte, Rosario Jiménez. Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation. American Journal of Physiology-Heart and Circulatory Physiology 2017; 312(2): H189 doi: 10.1152/ajpheart.00155.2016
|